Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary Prevention

September 11, 2018

In this program, experts James Underberg, MD, MS (Chair), Alan Brown, MD, Peter Jones, MD, and Pamela Morris, MD present compelling presentations and cases focusing on the evidence with, and use of, non-statin therapies for LDL-C lowering in the settings of primary and secondary prevention.

CME 0.00 Credits

LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy

June 17, 2018

n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.

CME 2.00 Credits

Improving Outcomes in Patients with Elevated LDL-Cholesterol: A Case-Based Series

January 01, 2018

An informative expert series of lectures including cases with the goal of improving outcomes in patients with elevated LDL-cholesterol

CME 1.50 Credits

Heart Failure Management: Exploring Best Practices for the Internist

September 26, 2017

Experts Dr. Javed Butler and Dr. James Januzzi provide helpful insights on the topic of Heart Failure and offer best practices on heart failure management.

CME 1.50 Credits

LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS

April 08, 2017

In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.

No Credit Available

The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies

November 08, 2016

In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.

No Credit Available

Optimizing Management of Recurrent Angina after PCI

May 08, 2015

Deepak Bhatt, MD, MPH, FSCAI (Chair); Duane Pinto, MD, FSCAI and Peter Stone, MD, MPH conduct a state-of-the-art discussion and case study on recurrent angina after PCI

No Credit Available

Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Treatment

April 29, 2015

Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.

No Credit Available

The Dynamics of In-Hospital and Post-Discharge ACS Management with Oral Antiplatelet Therapies

March 14, 2015

Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.

No Credit Available

Stable Ischemic Heart Disease Management: Challenges and Controversies

November 17, 2014

Valentin Fuster, MD, PhD (Co-Chair), Peter Stone, MD (Co-Chair) lead discussion of best practices and controversies in SIHD

No Credit Available

New Pathways to GLYCEMIC CONTROL: Focus on the Kidney

October 28, 2014

Presentations by Jay Shubrook, DO (Chair), Eugene Cersosimo, MD, PhD, and Robert Henry, MD. discussing the role of glucose regulation and SGLT 2 inhibitors in antihyperglycemic therapy

No Credit Available

Oral Antiplatelet Therapies for Acute Coronary Syndromes: State of the Art Management

September 15, 2014

Deepak Bhatt, MD, MPH (Chair), Paul Gurbel, MD, Robert Harrington, MD, Ajay Kirtane, MD, SM, Manesh Patel, MD, Marc Sabatine, MD, MPH and Philippe Gabriel Steg, MD discuss contemporary use of antiplatelet therapy and ACS management in lectures and cases.

No Credit Available